|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1998-12-9
|
|
pubmed:abstractText |
The aim of this study was to enhance the transdermal absorption of the highly active progestin gestodene from matrix type transdermal delivery systems (TDDS) by formation of prodrugs with improved matrix solubility.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0724-8741
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1419-24
|
|
pubmed:dateRevised |
2003-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9755895-Acylation,
pubmed-meshheading:9755895-Administration, Cutaneous,
pubmed-meshheading:9755895-Animals,
pubmed-meshheading:9755895-Biological Transport,
pubmed-meshheading:9755895-Contraceptives, Oral, Synthetic,
pubmed-meshheading:9755895-Crystallization,
pubmed-meshheading:9755895-Drug Delivery Systems,
pubmed-meshheading:9755895-Drug Design,
pubmed-meshheading:9755895-Drug Storage,
pubmed-meshheading:9755895-Gestonorone Caproate,
pubmed-meshheading:9755895-Male,
pubmed-meshheading:9755895-Mice,
pubmed-meshheading:9755895-Mice, Nude,
pubmed-meshheading:9755895-Norpregnenes,
pubmed-meshheading:9755895-Prodrugs,
pubmed-meshheading:9755895-Progesterone Congeners,
pubmed-meshheading:9755895-Solubility,
pubmed-meshheading:9755895-Temperature
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Prodrugs of gestodene for matrix-type transdermal drug delivery systems.
|
|
pubmed:affiliation |
Research Laboratories of Schering AG, Berlin, Germany. ralph.lipp@schering.de
|
|
pubmed:publicationType |
Journal Article
|
